US measles cases reach 4,080 in 2026, highest annual total since 1991 as Pennsylvania surges

The United States has crossed a threshold that public health officials spent a quarter century trying to avoid. The Centers for Disease Control and Prevention reported 4,080 confirmed measles cases nationwide as of October 8, 2026, the highest annual total since 1991 and nearly double the 2,289 cases recorded in all of 2025. The count rose by 193 cases in a single week, and it is still moving.

Measles is a highly contagious airborne respiratory illness that can lead to severe complications such as pneumonia. Before widespread vaccination, it circulated through nearly every American childhood. The country eliminated continuous transmission of the virus in 2000, a status that holds only as long as community vaccination coverage stays high enough to interrupt chains of infection.

That protection has been eroding. During the 2025-26 school year, 92.4 percent of kindergartners received the MMR vaccine, down from 95.2 percent in 2019-20 before the COVID-19 pandemic. The CDC says community vaccination rates above 95 percent are required to achieve herd immunity, the threshold at which the virus cannot sustain itself.

The 2026 outbreaks are geographically broad. Infections have been confirmed in 45 states and Washington, D.C., and the agency is tracking 42 active outbreaks across 47 jurisdictions. Pennsylvania has become the epicenter of the national surge, and New York has declared a statewide disaster emergency.

Key Facts

Reuters reported on October 9 that the CDC had confirmed 4,080 measles cases as of October 8, up 193 from a week earlier. The same dispatch noted that 26 cases were identified among international visitors, that 414 measles-related hospitalizations have been recorded this year, equal to about 10 percent of cases, compared with 244 hospitalizations in 2025, and that the CDC has confirmed two measles-associated deaths in 2026 without identifying the states involved. In 2025, the agency counted three deaths.

CGTN reported on October 10 that the 2026 total is nearly double the 2,289 cases recorded in all of 2025 and represents the highest annual figure since 1991. The report put 4,062 cases in United States jurisdictions and 18 additional cases involving international visitors, and it described 42 active outbreaks across 47 jurisdictions. CGTN also reported that unvaccinated individuals account for 95 percent of confirmed cases, and that patients aged 5 to 19 make up 42 percent of infections, followed closely by adults aged 20 and older at 40 percent.

ABC News reported on October 9 that cases surpassed 4,000 for the year, with most reported by 45 states and Washington, D.C. The network said 18 of this year's cases involved international visitors, that five measles-associated deaths have been confirmed in 2026 and that all five occurred in Pennsylvania, while the CDC has recognized only two, a number the agency says is subject to change. ABC News also reported that about 95 percent of cases are among people who are unvaccinated or whose vaccination status is unknown, with 2 percent among those who received one dose of the MMR vaccine and 2 percent among those who received the recommended two doses.

Reuters reported on October 9 that Pennsylvania health officials have reported 1,136 measles cases in 2026, including 219 hospitalizations, and that the state outbreak has produced five deaths. The same reporting placed children and teenagers aged 5 to 19 at the largest share of cases, 1,716 infections or 42 percent, with adults aged 20 and older at 1,635 cases, or 40 percent. New York declared a statewide disaster emergency earlier that week after reporting 108 cases this year through October 3, including 92 cases since July 15.

The CDC recommends two doses of the MMR vaccine, the first at 12 to 15 months and the second between 4 and 6 years. According to ABC News, one dose is 93 percent effective and two doses are 97 percent effective against measles. The agency has also shifted to using mortality data from the National Center for Health Statistics for measles-related deaths rather than relying on state health departments, a change made last month that has drawn scrutiny.

Analysis

What this really means is that the United States is no longer dealing with a series of unrelated local flare-ups but with a national transmission problem that has outgrown the containment playbook built after 2000. A country that recorded no continuous measles transmission for a generation is now seeing cases in 45 states and Washington, D.C., and tracking 42 active outbreaks across 47 jurisdictions. When the virus reaches that many jurisdictions in a single year, contact tracing and post-exposure prophylaxis stop being a strategy and become a race that local health departments cannot win.

Pennsylvania illustrates the shape of the failure. With 1,136 cases, 219 hospitalizations and five deaths, the state has produced the largest state-level outbreak in more than 30 years, and the deaths it reports outnumber the two the CDC has formally recognized for the entire country. That gap matters. It suggests the national picture may be less complete than the headline number implies, particularly after the CDC moved last month to use National Center for Health Statistics mortality data for measles-related deaths instead of relying on state health departments, a change that has drawn scrutiny.

The demographics point the same way. Children and teenagers aged 5 to 19 account for 1,716 cases, or 42 percent of infections, and adults aged 20 and older account for 1,635 cases, or 40 percent. About 95 percent of cases are among people who are unvaccinated or whose status is unknown, while only 2 percent are among people who received one dose of MMR and 2 percent among those who received two. That distribution is not the signature of a vaccine failure. It is the signature of a vaccination gap.

Dr. Peter Chin-Hong, an infectious diseases specialist and associate dean at the University of California, San Francisco, told ABC News that the pattern is 'very telling' and 'not a surprise, but it's chilling in many ways.' John Brownstein, an epidemiologist and chief innovation officer at Boston Children's Hospital, told the network that the tool exists, calling the vaccine 'incredibly effective' and saying the goal is to close vaccination gaps. He added that there is a 'very strong chance that we would lose our elimination status because we're seeing the signs that measles is becoming continuously established here in the US.'

Why It Matters

Measles elimination status is not an abstraction. The United States has held it since 2000, and losing it would mean the virus is again circulating continuously inside the country rather than arriving only in imported clusters. Brownstein's warning about a 'very strong chance' of losing that status, combined with 42 active outbreaks and cases in 45 states, puts the milestone within reach of a single bad season. That change would reshape how every pediatric practice, school district and hospital infection-control team plans its year.

The clinical burden is already visible. Hospitalizations stand at 414, about 10 percent of confirmed cases, up from 244 in 2025, and ABC News reported on October 9 that about one in 10 children under age 5 has been hospitalized this year. Measles complications include pneumonia, and the youngest patients are the most vulnerable. A disease that once filled pediatric wards before the vaccine era can do so again when coverage slips.

Vaccination coverage is the variable that decides everything else. Kindergarten MMR coverage of 92.4 percent in the 2025-26 school year sits below the 95.2 percent recorded in 2019-20 and below the roughly 95 percent threshold the CDC cites for herd immunity. The 2026 case distribution, with about 95 percent of infections in unvaccinated people or those of unknown status, shows precisely where the virus is finding room to spread.

Next Up

The next few weeks of CDC updates will show whether the weekly increase of 193 cases recorded in the October 9 report was a peak or a waypoint. Pennsylvania's case count, New York's emergency measures and the agency's newly adopted mortality reporting method will all be watched closely, as will the question of whether the national death toll is revised upward from the two cases the CDC has so far recognized.

Public health officials will also be pushing MMR catch-up campaigns into the communities where coverage has fallen, since the vaccine remains 93 percent effective after one dose and 97 percent after two. Whether the country keeps its elimination status may depend on how quickly those gaps close before the next school year begins.